Latest news with #SkyLabs
Korea Herald
29-04-2025
- Health
- Korea Herald
Sky Labs' CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea and the developer of CART BP pro—a ring-type, cuffless device for 24-hour blood pressure monitoring—announced that a research presentation by Professor Jin Oh Na introduced the application of CART BP pro in exploring the relationship between sleep and cardiovascular patterns, offering an opportunity to gain deeper insights into cardiovascular risks during sleep. This study represents a meaningful step forward in cardiovascular research. Until now, studying the connection between sleep-disordered breathing and hypertension has been limited due to constraints in traditional measurement tools. With CART BP pro, researchers can gather uninterrupted blood pressure data, offering an opportunity to better understand cardiovascular patterns during sleep. Professor Jin Oh Na of Korea University Guro Hospital's Cardiovascular Center presented a research plan under the theme " Sleep and Cardiovascular Health: Why It Matters" at the 2025 Annual Spring Scientific Conference of the Korean Society of Cardiology. His upcoming research will explore the correlation between sleep apnea and cardiovascular risks using CART BP pro to measure blood pressure noninvasively during sleep. "Obstructive sleep apnea is a condition that affects cardiovascular health but is frequently underdiagnosed. In Korea, about 85% of OSA patients remain undiagnosed, often dismissed as simple snoring," said Professor Na. "We are planning a study to measure nighttime blood pressure every five minutes using CART BP pro, with the aim of developing a model that may help identify patients at risk and support long-term assessment." CART BP pro offers several advantages for both clinical practice and research: Professor Na pointed out that while polysomnography (PSG) is the current gold standard for diagnosing sleep apnea, it does not allow for precise blood pressure monitoring during sleep. He explained that cuff-based devices may disturb sleep due to pressure inflation and are not suitable for high-frequency nocturnal measurements. By using CART BP pro, researchers expect to collect more consistent, real-world data without interfering with sleep. The 2025 Annual Spring Scientific Conference held from April 17 to 19 in Busan, Korea, was jointly hosted with the 29th Asian Pacific Society of Cardiology Congress and attended by leading cardiology experts from across the region. Currently available at more than 1,300 hospitals and clinics throughout South Korea, CART BP pro has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) and is eligible for national health insurance reimbursement, making it more accessible to a broader range of patients. About Sky Labs Founded in September 2015, Sky Labs is a leading healthcare startup that has developed CART (Cardio Tracker), a ring-shaped medical device designed for disease monitoring using heart signals collected through optical sensors. Following this, the company developed CART BP, a cuffless, ring-shaped device that enables 24-hour blood pressure monitoring, providing valuable treatment information and making a groundbreaking contribution to improving the quality of life for hypertension patients. Sky Labs has signed an exclusive domestic distribution agreement for CART BP pro with South Korea's Daewoong Pharmaceutical and is preparing for nationwide sales to hospitals, clinics, and general consumers.
Associated Press
28-04-2025
- Health
- Associated Press
Sky Labs' CART BP pro at the Heart of New Research on Sleep Apnea and Nocturnal Hypertension
SEOUL, South Korea, April 28, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea and the developer of CART BP pro—a ring-type, cuffless device for 24-hour blood pressure monitoring—announced that a research presentation by Professor Jin Oh Na introduced the application of CART BP pro in exploring the relationship between sleep and cardiovascular patterns, offering an opportunity to gain deeper insights into cardiovascular risks during sleep. This study represents a meaningful step forward in cardiovascular research. Until now, studying the connection between sleep-disordered breathing and hypertension has been limited due to constraints in traditional measurement tools. With CART BP pro, researchers can gather uninterrupted blood pressure data, offering an opportunity to better understand cardiovascular patterns during sleep. Professor Jin Oh Na of Korea University Guro Hospital's Cardiovascular Center presented a research plan under the theme 'Sleep and Cardiovascular Health: Why It Matters' at the 2025 Annual Spring Scientific Conference of the Korean Society of Cardiology. His upcoming research will explore the correlation between sleep apnea and cardiovascular risks using CART BP pro to measure blood pressure noninvasively during sleep. 'Obstructive sleep apnea is a condition that affects cardiovascular health but is frequently underdiagnosed. In Korea, about 85% of OSA patients remain undiagnosed, often dismissed as simple snoring,' said Professor Na. 'We are planning a study to measure nighttime blood pressure every five minutes using CART BP pro, with the aim of developing a model that may help identify patients at risk and support long-term assessment.' CART BP pro offers several advantages for both clinical practice and research: Professor Na pointed out that while polysomnography (PSG) is the current gold standard for diagnosing sleep apnea, it does not allow for precise blood pressure monitoring during sleep. He explained that cuff-based devices may disturb sleep due to pressure inflation and are not suitable for high-frequency nocturnal measurements. By using CART BP pro, researchers expect to collect more consistent, real-world data without interfering with sleep. The 2025 Annual Spring Scientific Conference held from April 17 to 19 in Busan, Korea, was jointly hosted with the 29th Asian Pacific Society of Cardiology Congress and attended by leading cardiology experts from across the region. Currently available at more than 1,300 hospitals and clinics throughout South Korea, CART BP pro has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) and is eligible for national health insurance reimbursement, making it more accessible to a broader range of patients. About Sky Labs Founded in September 2015, Sky Labs is a leading healthcare startup that has developed CART (Cardio Tracker), a ring-shaped medical device designed for disease monitoring using heart signals collected through optical sensors. Following this, the company developed CART BP, a cuffless, ring-shaped device that enables 24-hour blood pressure monitoring, providing valuable treatment information and making a groundbreaking contribution to improving the quality of life for hypertension patients. Sky Labs has signed an exclusive domestic distribution agreement for CART BP pro with South Korea's Daewoong Pharmaceutical and is preparing for nationwide sales to hospitals, clinics, and general consumers. Media Inquiries Edelman Korea [email protected] View original content to download multimedia: SOURCE Sky Labs
Korea Herald
22-04-2025
- Health
- Korea Herald
UK Clinical Study Finds Sky Labs' Smart Ring 'CART-I' More Sensitive Than Apple Watch for AFib Detection
SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea, announced that its ring-shaped smart medical device, CART-I (Cardio Tracker), demonstrated higher sensitivity than the Apple Watch in detecting atrial fibrillation (AFib) in a recent clinical study. The study's findings were published in Heart Rhythm O 2, a peer-reviewed international journal. "This study offers strong external validation of CART-I's performance in detecting atrial fibrillation," said Jack Lee, CEO of Sky Labs. "Together with CART BP, which focuses on hypertension management, these results demonstrate CART-I's potential to support broader cardiovascular monitoring in the future. We will continue to develop medical devices that deliver both accuracy and convenience for patients." The comparative study, conducted across three hospitals in the UK (Oxford University Hospital, University Hospital Southampton, and Queen Elizabeth Hospital), involved approximately 500 patients and evaluated CART-I and Apple Watch under the same clinical protocol. Researchers assessed the sensitivity and specificity of each device's automatic AFib detection algorithms using single-lead electrocardiograms (SL-ECG) data, which was subsequently interpreted by physicians. Results showed that Sky Labs' CART-I achieved 84.6% sensitivity, while Apple Watch recorded 69.1% under the same protocol. Both devices also demonstrated high performance in physician interpretation of SL-ECGs: the Apple Watch scored 95.4% sensitivity, and CART-I recorded 94.3%. Unlike prior studies that focused solely on atrial fibrillation, this research is especially meaningful for its inclusion of a broad range of arrhythmias such as atrial flutter and atrial tachycardia. Researchers noted, however, that wearable devices alone are not yet sufficient for diagnosing specific arrhythmias such as atrial flutter or atrial tachycardia. Physician interpretation remains essential, and automated algorithms should be considered as supportive tools rather than standalone diagnostic solutions. Separately, Sky Labs' cuffless ring-type blood pressure monitor, CART BP, was recently awarded the 2024 Prime Minister's Prize at the IR52 Jang Young-sil Awards, one of Korea's most prestigious recognitions for technological innovation. CART BP was selected for fulfilling all four key evaluation criteria: economic value, technological importance, originality, and technological independence. CART BP is an innovative medical device that transforms traditional blood pressure monitoring by replacing cuff-based, intermittent arm measurements with comfortable, finger-based monitoring over a 24-hour period. The device received regulatory approval from the Korean Ministry of Food and Drug Safety in 2023 and was approved for national health insurance reimbursement in 2024. As of April 2025, CART BP pro is in use at more than 1,300 hospitals and clinics across South Korea, supporting daily blood pressure monitoring and management. About Sky Labs Founded in September 2015, Sky Labs is a leading healthcare startup that has developed CART (Cardio Tracker), a ring-shaped medical device designed for disease monitoring using heart signals collected through optical sensors. Following this, the company developed CART BP, a cuffless, ring-shaped device that enables 24-hour blood pressure monitoring, providing valuable treatment information and making a groundbreaking contribution to improving the quality of life for hypertension patients. Sky Labs has signed an exclusive domestic distribution agreement for CART BP pro with South Korea's Daewoong Pharmaceutical and is preparing for nationwide sales to hospitals, clinics, and general consumers.
